Rutinib.com is an educational pharmaceutical-information website focused on three ruxolitinib products:
- Rutinib Cream
- Rutinib 5 mg
- Ruxotor 10 mg
The website explains the relationship between these products while maintaining an important distinction between topical and oral treatment.
Our Editorial Approach
Content is developed around:
- regulatory information
- official prescribing information
- clinical evidence
- pharmaceutical references
- product documentation
- responsible health communication
Three-Product Approach
Rutinib.com does not treat ruxolitinib as a single universal product.
The website distinguishes:
Topical ruxolitinib → Rutinib Cream
Oral ruxolitinib → Rutinib 5 mg
Oral ruxolitinib → Ruxotor 10 mg
This distinction is particularly important for dosage, indications, safety and clinical evidence.
Educational Purpose
The website provides general information and does not replace a physician, pharmacist or official prescribing information.
No medical reviewer, doctor or pharmacist should be identified as part of the website unless that person’s credentials have been independently established.